CLF Stock UPDATES Cliffs Natural Resources Inc (CLF) 17.35 08/04/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cliffs Natural Resources Inc (CLF) 17.35 $CLF

Casablanca Capital Comments on Cliffs Natural Resources' Acknowledgement That All Six Casablanca Director Nominees Have Been Elected to Board
Business Wire - 2 hrs 52 mins ago
Casablanca Capital LP, ("Casablanca" the beneficial owner of approximately 5.2% of Cliffs Natural Resources (NYSE:CLF) ("Cliffs" shares, today issued the following statement regarding Cliffs' acknowledgement that shareholders have elected all six of Casablanca's nominees to the Company's 11-member Board of Directors:

Next Resistance Level for Cliffs Natural Resources (CLF) is $18.04
Comtex SmarTrend(R) - Mon Aug 04, 9:36AM CDT
Shares of Cliffs Natural Resources (NYSE:CLF) have bullishly opened above the pivot of $17.29 today and have reached the first resistance level of $17.69. Analysts will be watching for a cross of the next upside pivot targets of $18.04 and $18.79.

Will This Analyst Upgrade Help Cliffs Natural Resources (CLF) Stock Today?
at The Street - Thu Jul 31, 8:13AM CDT
Bernstein upgraded Cliffs Natural Resources (CLF) to "market perform" from "underperform" and set a $16 price target.

Upgrade Alert for Cliffs Natural Resources (CLF)
Comtex SmarTrend(R) - Thu Jul 31, 7:02AM CDT
Cliffs Natural Resources (NYSE:CLF) was upgraded from Underperform to Market Perform at Bernstein today. The stock closed yesterday at $17.23 on volume of 6.6 million shares, above average daily volume of 5.6 million. Cliffs Natural Resources share prices have moved between a 52-week high of $28.98 and a 52-week low of $13.60 and closed yesterday at 27% above that low price at $17.23 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has slid 0.3%.

Activist Gains Board Control at Cliffs Natural Resources
at The Street - Wed Jul 30, 8:25AM CDT
Activist hedge fund Casablanca Capital said Tuesday that all six of its nominees have been elected to the board of Cliffs Natural Resources.

NYSE stocks posting largest percentage increases
AP - Tue Jul 29, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:

Cliffs Natural Resources Rises 6.21% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jul 29, 4:19PM CDT
Cliffs Natural Resources (NYSE:CLF) traded in a range yesterday that spanned from a low of $16.33 to a high of $18.33. Yesterday, the shares gained 6.2%, which took the trading range above the 3-day high of $16.69 on volume of 17.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Cliffs Natural Resources Set to Possibly Pullback After Yesterday's Rally of 6.21%
Comtex SmarTrend(R) - Tue Jul 29, 4:18PM CDT
Cliffs Natural Resources (NYSE:CLF) traded in a range yesterday that spanned from a low of $16.33 to a high of $18.33. Yesterday, the shares gained 6.2%, which took the trading range above the 3-day high of $16.69 on volume of 17.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Cliffs Natural Resources Stock Surges as Activist Hedge Fund Wins Board Majority
at The Street - Tue Jul 29, 2:01PM CDT
Cliffs Natural Resources shareholders have voted in favor of a majority slate of directors proposed by fledgling activist hedge fund Casablanca Capital.

Why Cliffs Natural Resources (CLF) Stock Is Soaring Today
at The Street - Tue Jul 29, 12:52PM CDT
Shares of Cliffs Natural Resources (CLF) are soaring after activist investor Casablanca Capital said it won control of the board after a six month proxy fight.

Cliffs Natural Resources Inc. Issues Statement
Business Wire - Tue Jul 29, 12:46PM CDT
Cliffs Natural Resources Inc. (NYSE:CLF) today made the following statement following the Company's Annual General Meeting:

Casablanca Receives Overwhelming Shareholder Support for Change at Cliffs Natural Resources
Business Wire - Tue Jul 29, 11:31AM CDT
--According to Preliminary Voting Results

Cliffs Natural Resources' board to pay dividend to holders of record of 15 August 2014
M2 - Tue Jul 29, 7:05AM CDT
The board of directors of Cliffs Natural Resources (NYSE:CLF), a mining company, declared on Monday its quarterly dividend of USD0.15 per share on its common stock.

'Fast Money' Recap: Playing China Through U.S. Stocks
at The Street - Tue Jul 29, 4:00AM CDT
The trading panel looked at the Shanghai composite index and how investors can use U.S. stocks as a proxy.

Cliffs Natural Resources Inc. Declares Quarterly Cash Dividend on Common Shares
GlobeNewswire - Mon Jul 28, 4:46PM CDT
Cliffs Natural Resources Inc. (NYSE:CLF) today announced that its Board of Directors declared a quarterly cash dividend on the Company's common shares of $0.15 per share. The cash dividend will be payable on Sept. 2, 2014, to shareholders of record as of the close of business on Aug. 15, 2014.

Why Cliffs Natural Resources (CLF) Stock Is Up Today
at The Street - Mon Jul 28, 12:04PM CDT
Cliffs Natural Resources (CLF) is gaining Monday after Macquarie upgraded the stock to 'neutral' from 'underperform' ahead of the company's annual general meeting.

Cliffs Natural Resources (CLF) Crosses Pivot Point Resistance at $16.50
Comtex SmarTrend(R) - Mon Jul 28, 9:03AM CDT
Shares of Cliffs Natural Resources (NYSE:CLF) opened today above their pivot of $15.77 and have already reached the first level of resistance at $16.50. Analysts will be watching for a cross of the next upside pivot targets of $16.90 and $18.03.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading